Trial Profile
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Sumitomo Pharma America
- 01 Feb 2010 Results published in Sleep.
- 09 Sep 2008 Endpoint 'Wake time after sleep onset' has been met.
- 09 Sep 2008 Endpoint 'Sleep latency' has been met.